Shanghai RAAS Blood Products Co., Ltd.
002252
Rangering i aksjer
#3644
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aksjekurs
$0.70717976
Markedsverdi
$4.66B
Endring (1 dag)
0.00%
Endring (1 år)
-24.71%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategori
Healthcare
Utbytteavkastning for Shanghai RAAS Blood Products Co., Ltd. (002252)
Shanghai RAAS Blood Products Co., Ltd. (aksjesymbol: 002252) sin utbytteavkastning (TTM) per 2023-12-31 er: 0.40%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.45%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.45%
Utbytteavkastning for Shanghai RAAS Blood Products Co., Ltd. (002252) fra 2005 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| 2026 (TTM) | 0.97% | 5.43% |
| 2024 | 0.92% | 130.00% |
| 2023 | 0.40% | -9.09% |
| 2022 | 0.44% | 18.92% |
| 2021 | 0.37% | 164.29% |
| 2020 | 0.14% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | 0.43% | 95.45% |
| 2017 | 0.22% | 46.67% |
| 2016 | 0.15% | 7.14% |
| 2015 | 0.14% | -6.67% |
| 2014 | 0.15% | 200.00% |
| 2013 | 0.05% | -95.10% |
| 2012 | 1.02% | 21.43% |
| 2011 | 0.84% | 33.33% |
| 2010 | 0.63% | -42.20% |
| 2009 | 1.09% | 45.33% |
| 2008 | 0.75% | -59.89% |
| 2007 | 1.87% | -9.66% |
| 2006 | 2.07% | 567.74% |
| 2005 | 0.31% | 0.00% |
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
